Design
Editorial
Answers are grounded in this paper and cite their sources.
Highlights the challenges in defining and diagnosing pulmonary vascular disease in the context of heart failure.
Pulmonary hypertension (PH), defined as a mean pulmonary arterial pressure (PAP) ≥25 mmHg, is a well-recognised complication of left heart disease (LHD). PH prevalence is variable ranging from 25% to 80% of LHD patients according to the methods of assessment, cut-off values and characteristics of the patient population [1–3]. All aetiological types of LHD are affected, including heart failure with reduced (HFrEF) or preserved (HFpEF) left ventricular ejection fraction, and valvular LHD. The presence of PH-LHD is associated with advanced symptoms, reduced exercise capacity and impaired outcome after medical, interventional or surgical therapy [1, 3, 4]. Definition and diagnosis of pulmonary vascular disease in heart failure: still an unclear rebus <http://ow.ly/qp1L300x6yY>
No takes yet. Share an insight, caveat, or question.
Galiè et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: